<https://rdf.molmedb.upol.cz/reference/ref3809> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM492095>,
		<https://identifiers.org/molmedb/MM492094>;
	<http://purl.org/ontology/bibo/pmid> "22521646"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM492096>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/bibliographicCitation> "Aiguadé J, Balagué C, Carranco I, Caturla F, Domínguez M, Eastwood P, Esteve C, González J, Lumeras W, Orellana A, Preciado S, Roca R, Vidal L, Vidal B.: Novel triazolopyridylbenzamides as potent and selective p38α inhibitors. Bioorg Med Chem Lett, Volume 22 (10), 2012"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2012.03.099"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21> .
<https://rdf.molmedb.upol.cz/interaction/int1026974> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3809> .
<https://rdf.molmedb.upol.cz/interaction/int1026975> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3809> .
<https://rdf.molmedb.upol.cz/interaction/int1026962> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3809> .
<https://rdf.molmedb.upol.cz/interaction/int1026961> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3809> .
<https://rdf.molmedb.upol.cz/interaction/int1026973> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3809> .